Records containing: Major Depressive Disorder
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-30MicroRNA Correlates of Childhood Maltreatment and Suicidality
-
CLINICAL_TRIALS study record update · 2026-03-27Remote Cognitive Behavior Therapy for Major Depression (RTD) in Primary Care
-
CLINICAL_TRIALS study record update · 2026-03-27Alexithymia Intervention for Suicide (ALEXIS)
-
CLINICAL_TRIALS study record update · 2026-03-27Study of Electrophysiological Markers of Antidepressants in Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2026-03-27Sustained Mood Improvement With Laughing Gas Exposure: A Randomized Controlled Pilot Trial - Sub-Study Protocol to Include Neuroimaging
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-27Brain Changes During Social Reward Psychotherapy for Mid- and Late-Life Suicidality: A Precision Imaging Trial
-
CLINICAL_TRIALS study record update · 2026-03-25Neutralizing Interleukin (IL)-6 Signaling to Reverse Immune Related Anhedonia in Patients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2026-03-25Clinical Efficacy of Intradermal Acupuncture as an Adjunct to SSRI Dose Reduction or Discontinuation in Patients With Major Depressive Disorder and Its Mechanisms of Autonomic Nervous System Regulation
-
CLINICAL_TRIALS study record update · 2026-03-23A Phase 2, Multicenter, 6-Week, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Icalcaprant in Subjects With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2026-03-23Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression
-
CLINICAL_TRIALS study record update · 2026-03-20A Phase 2, Multicenter, Randomized, Double-blind Evaluation of the Efficacy and Safety of Oral GATE-251 or Placebo for the Reduction of Symptoms of Major Depressive Disorder in Adults
-
CLINICAL_TRIALS study record update · 2026-03-19Understanding the Neurocognitive Effects of Fecal Microbiota Transplantation in Major Depressive Disorder Patients With and Without Irritable Bowel Syndrome
-
CLINICAL_TRIALS study record update · 2026-03-19A Double-Blind Randomized Controlled Trial Evaluating the Efficacy of Repetitive Transcranial Magnetic Stimulation (rTMS) as Treatment for Major Depressive Disorder in Transition-Age Youth With Autism Spectrum Disorder
-
CLINICAL_TRIALS study record update · 2026-03-19A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Maintenance of Effect of NBI-1065845 as an Adjunctive Treatment in Subjects With Major Depressive Disorder (MDD)
-
CLINICAL_TRIALS study record update · 2026-03-18Pilot Study: Evaluating the Feasibility of Repetitive Transcranial Magnetic Stimulation Treatment Delivered at Individual-based, SCC-determined Frequency in Subjects Suffering From Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2026-03-18Optimize and Predict Antidepressant Efficacy for Patient With Major Depressive Disorders Using Multi-omics Analysis and AI-predictive Tool
-
CLINICAL_TRIALS study record update · 2026-03-17A Feasibility Study of Transcranial Electric Stimulation Therapy (TEST) for Treatment Resistant Depression (TRD)
-
CLINICAL_TRIALS study record update · 2026-03-16Multimodal Clinical Study of Electroconvulsive Therapy and Magnetic Seizure Therapy
-
CLINICAL_TRIALS study record update · 2026-03-13A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled, 12-Week Study (Part A) With a 40-Week Open-label Extension (Part B) Evaluating the Efficacy and Safety of Oral MM120 Compared to Placebo in the Treatment of Adults With Major Depressive Disorder - Emerge
-
CLINICAL_TRIALS study record update · 2026-03-13Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder
-
CLINICAL_TRIALS study record update · 2026-03-13ActiveCBT for Depression: Transforming Treatment Through Exercise Priming
-
CLINICAL_TRIALS study record update · 2026-03-12Towards Identification of Genetic and Neural Predictors of Adolescent Depression
-
CLINICAL_TRIALS study record update · 2026-03-12A Phase 1, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of AGN-241751 After Oral Administration in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2026-03-12Investigating the Neural Mechanisms of Repetitive Brain Stimulation With Invasive and Noninvasive Electrophysiology in Humans
-
CLINICAL_TRIALS study record update · 2026-03-11A Phase III Long-Term Extension Trial With Optional Additional Doses of CYB003 to Assess the Safety and Long-term Efficacy in Participants With Major Depressive Disorder (EXTEND)